Sven Taylor

This inventor holds 35 USPTO granted patents and 1 published patent application and 13 EPO patents, primarily in Benzimidazole Derivatives. Top assignees: Hoffmann-La Roche Inc., Vernalis Research Limited, Vernal Research Limited. Active years: 1996-2012.

USPTO Granted Patents = 35 (Patent Applications = 1)

% Patents Active = 17.1

EPO Patents = 13 (Patent Applications = 10)

Average Co-Inventor Count = 5.1

ph-index = 5

Forward Citations = 66(Granted Patents)

Company Filing History:

33 out of 5,011

Hoffmann-La Roche Inc.

patents

2 out of 43

Vernalis Research Limited

patents

1 out of 1

Vernal Research Limited

patent

4. 2 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2012

Loading Chart...

Areas of Expertise:

Benzimidazole

Indazole

Thiazole

Piperazine

Azaindole

Tricyclic Amides

Fused Indole

Spiro Compounds

Heterocyclic Antagonists

Protein Kinase Inhibitors

Cyclopentyl

Cycloheptyl

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8309581 - Benzimidazole derivatives (2012-11-13),

2. 8252826 - Cyclopentyl- and cycloheptylpyrazoles (2012-08-28),

3. 8153663 - 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives (2012-04-10),

4. 8143422 - Benzimidazole derivatives (2012-03-27),

5. 8088930 - Benzimidazole derivatives (2012-01-03),

6. 8008505 - Indazole or 4,5,6,7-tetrahydro-indazole derivatives (2011-08-30),

7. 8008503 - Methyl-benzimidazole derivatives (2011-08-30),

8. 7825258 - Methyl-benzimidazole derivatives (2010-11-02),

9. 7816540 - Carboxyl- or hydroxyl-substituted benzimidazole derivatives (2010-10-19),

10. 7790904 - Substituted benzimidazole derivatives (2010-09-07),

11. 7786109 - Tricyclic amide derivatives as modulators of H3 receptors (2010-08-31),

12. 7745479 - 1,5-substituted indol-2-yl amide derivatives (2010-06-29),

13. 7723325 - 5-amido-indole-2-carboxamide derivatives (2010-05-25),

14. 7648979 - 5-amido-(1H-indol-2-yl)-piperazin-1-yl-methanone derivatives (2010-01-19),

15. 7622466 - Azaindole-2-carboxamide derivatives (2009-11-24),

Sure, I can help with that! Here's the article about inventor Sven Taylor:

Title: Sven Taylor: A Visionary Inventor in Sustainable Innovations

Introduction:

Sven Taylor, hailing from Riedisheim, FR, has carved a name for himself in the industry through his dedication to creating sustainable and impactful innovations. With a remarkable portfolio of 35 patents, Taylor’s work showcases his visionary approach to inventing.

Latest Patents:

1. Benzimidazole Derivatives: Taylor's latest patent involves compounds of formula (I), including pharmaceutically acceptable salts, which have applications in pharmaceutical compositions.

2. Cyclopentyl- and Cycloheptylpyrazoles: Another recent invention by Taylor, these novel derivatives have promising applications and are accompanied by physiologically acceptable salts.

Career Highlights:

Taylor has made significant contributions to notable companies such as Hoffmann-La Roche Inc. and Vernalis Research Limited, where he played a key role in driving innovation and research in the pharmaceutical industry.

Collaborations:

Throughout his career, Taylor has collaborated with esteemed colleagues, including Hans G. Richter and Jean-Marc Plancher. These collaborations have been instrumental in bringing his innovative concepts to life and making a lasting impact on the field.

Conclusion:

Sven Taylor's unwavering commitment to sustainable and impactful innovations, coupled with his extensive patent portfolio and collaborations with industry experts, solidifies his position as a visionary inventor in the industry. His contributions continue to shape the landscape of sustainable innovation, leaving a lasting legacy for future inventors to follow.